Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares

GuruFocus.com09-14

On September 11, 2024, David Zaccardelli, President and Chief Executive Officer of Verona Pharma PLC (NASDAQ:VRNA), sold 600,000 shares of the company. The transaction was documented in a recent SEC ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2467635450?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/rOnGOB3W01qEj2.ZuEhoyQ--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/6203baed729a297ccd21094958790175","is_english":true,"pubTime":"2024-09-14 13:51","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2467635450","market":"us","top_or_hot":-1,"title":"Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares","media":"GuruFocus.com","content":"<div>\n<p>On September 11, 2024, David Zaccardelli, President and Chief Executive Officer of Verona Pharma PLC (NASDAQ:VRNA), sold 600,000 shares of the company. The transaction was documented in a recent SEC ...</p>\n\n<a href=\"https://finance.yahoo.com/news/verona-pharma-plc-vrna-ceo-055153455.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVerona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-14 13:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/verona-pharma-plc-vrna-ceo-055153455.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On September 11, 2024, David Zaccardelli, President and Chief Executive Officer of Verona Pharma PLC (NASDAQ:VRNA), sold 600,000 shares of the company. The transaction was documented in a recent SEC ...</p>\n\n<a href=\"https://finance.yahoo.com/news/verona-pharma-plc-vrna-ceo-055153455.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VRNA","symbol_name":"维罗纳制药","start_time":0,"source_url":"https://finance.yahoo.com/news/verona-pharma-plc-vrna-ceo-055153455.html","article_id":"2467635450","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/rOnGOB3W01qEj2.ZuEhoyQ--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/6203baed729a297ccd21094958790175"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2467635450","pubTimestamp":1726293113,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"On September 11, 2024, David Zaccardelli, President and Chief Executive Officer of Verona Pharma PLC , sold 600,000 shares of the company. The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 15,250,704 shares of Verona Pharma PLC.GuruFocus has detected 2 Warning Sign with VRNA.Over the past year, David Zaccardelli has sold a total of 1,000,000 shares and has not made any purchases of the company's stock. This recent sale is part of a broader trend observed at Verona Pharma PLC, where insider transactions over the past year have included 3 buys and 7 sells.On the date of the sale, shares of Verona Pharma PLC were trading at $3.76, giving the company a market cap of approximately $2.42 billion. This valuation reflects the company's position and potential within the biopharmaceutical industry, focusing on respiratory health solutions.For more detailed information on Verona Pharma PLC's valuation metrics such as GF Value, price-earnings ratio, p","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"VRNA":"维罗纳制药","BK4007":"制药"},"translate_title":"Verona Pharma PLC(VRNA)首席执行官David Zaccardelli出售600,000股股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VRNA":1},"content_text":"On September 11, 2024, David Zaccardelli, President and Chief Executive Officer of Verona Pharma PLC (NASDAQ:VRNA), sold 600,000 shares of the company. The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 15,250,704 shares of Verona Pharma PLC.\n\nWarning! GuruFocus has detected 2 Warning Sign with VRNA.\n\nVerona Pharma PLC is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for respiratory diseases. The company's focus is on products that are designed to meet the needs of patients with conditions such as chronic obstructive pulmonary disease and cystic fibrosis.\nOver the past year, David Zaccardelli has sold a total of 1,000,000 shares and has not made any purchases of the company's stock. This recent sale is part of a broader trend observed at Verona Pharma PLC, where insider transactions over the past year have included 3 buys and 7 sells.\nOn the date of the sale, shares of Verona Pharma PLC were trading at $3.76, giving the company a market cap of approximately $2.42 billion. This valuation reflects the company's position and potential within the biopharmaceutical industry, focusing on respiratory health solutions.\nFor more detailed information on Verona Pharma PLC's valuation metrics such as GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, investors and analysts can visit the respective links.\nThis article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.This article first appeared on \nGuruFocus.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2467635450"}